Mary Coleman
Investor Relations Contact at CATALYST PHARMACEUTICALS, INC.
Mary Coleman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Investor Relations Contact | 2021-08-15 | - |
Career history of Mary Coleman
Former positions of Mary Coleman
| Companies | Position | Start | End |
|---|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Investor Relations Contact | - | - |
| AGILE THERAPEUTICS, INC. | Investor Relations Contact | - | - |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Investor Relations Contact | 2017-12-31 | - |
| Public Communications Contact | 2017-12-31 | - | |
| SAVIENT PHARMACEUTICALS INC | Investor Relations Contact | - | - |
| Public Communications Contact | 2010-08-30 | - |
Training of Mary Coleman
| Bowling Green State University | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Investor Relations Contact | 5 |
| Public Communications Contact | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
- Stock Market
- Insiders
- Mary Coleman
- Experience
